Get the Stockscreener App
9.885
5.16%
0.485
After Hours:
9.91
0.025
+0.25%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Core Laboratories Inc Stock (CLB) Forecast
The Core Laboratories Inc (CLB) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $9.3508, representing a -5.40% decrease from the current price of $9.885. The highest analyst price target is $12.38, and the lowest is $6.3198.
Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CLB Price Target
Average 10.08
(+1.95% Upside)
Is Core Laboratories Inc (CLB) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 42.21 | Neutral |
| STOCH(9,6) | 58.57 | Neutral |
| STOCHRSI(14) | 97.21 | Sell |
| MACD(12,26) | -0.342 | Buy |
| ADX(14) | 32.60 | Sell |
| William %R | -48.99 | Neutral |
| CCI(14) | -102.87 | Sell |
Buy: 1
Sell: 3
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
9.9345
Sell
|
9.9388
Sell
|
| MA20 |
9.9818
Sell
|
10.17
Sell
|
| MA50 |
11.20
Sell
|
10.82
Sell
|
| MA100 |
11.44
Sell
|
11.69
Sell
|
| MA200 |
14.08
Sell
|
12.55
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, CLB could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 13 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on CLB, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 42.21 indicates that CLB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 58.57 indicates that CLB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 97.21 indicates that CLB is oversold. This suggests that CLB price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 32.6 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -102.87 indicates that CLB is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term CLB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Core Laboratories Inc financial reports and earnings history, Core Laboratories Inc (CLB) stock could reach $9.3407 by 2030, $14.95 by 2040 and $51.87 by 2050. See the projected annual prices until 2050 of the Core Laboratories Inc stock below:
- Core Laboratories Inc (CLB) is expected to reach an average price of $8.9198 in 2035, with a high prediction of $8.3502 and a low estimate of $7.9837. This indicates an $-9.76% rise from the last recorded price of $9.885.
- Core Laboratories Inc (CLB) stock is projected to chart a bullish course in 2040, with an average price target of $14.41, representing an $45.75% surge from its current level. The forecast ranges from a conservative $16.01 to a sky-high $14.95.
- Our analysts predict Core Laboratories Inc (CLB) to jump 284.32% by 2045, soaring from $35.74 to an average price of $37.99, potentially reaching $36.81. While $35.74 is the low estimate, the potential upside is significant.
- Core Laboratories Inc (CLB) stock is expected to climb by 2050, reaching an average of $49.36, a $399.32% jump from its current level. However, a wide range of estimates exists, with high and low targets of $51.87 and $52.46, respectively, highlighting the market's uncertainty.
Core Laboratories Inc Stock (CLB) Year by Year Forecast
Core Laboratories Inc Stock (CLB) Price Forecast for 2026
The predicted value for Core Laboratories Inc (CLB) in 2026 is set at an average of $12.56. Estimates vary from a peak of $20.36 to a trough of $4.7577, indicating an +27.05% surge from the present price of $9.885.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $6.4598 | $6.3198 | $12.38 | -34.65% |
| December, 2026 | $6.9636 | $4.7577 | $9.4617 | -29.55% |
Core Laboratories Inc Stock (CLB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Core Laboratories Inc (CLB) is $10.08, with a high forecast of $20.01 and a low forecast of $0.1451. This indicates an +1.95% increase from the last price of $9.885.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $9.7674 | $5.7196 | $11.95 | -1.19% |
| February, 2027 | $12.14 | $8.4153 | $12.47 | +22.83% |
| March, 2027 | $15.96 | $9.0732 | $20.01 | +61.47% |
| April, 2027 | $16.75 | $12.90 | $17.19 | +69.50% |
| May, 2027 | $11.97 | $9.1247 | $18.46 | +21.14% |
| June, 2027 | $12.83 | $6.3506 | $13.84 | +29.78% |
| July, 2027 | $3.9223 | $3.2023 | $16.14 | -60.32% |
| August, 2027 | $2.2821 | $0.1451 | $5.7483 | -76.91% |
| September, 2027 | $1.4859 | $0.9959 | $4.428 | -84.97% |
| October, 2027 | $3.3497 | $0.4438 | $3.3797 | -66.11% |
| November, 2027 | $1.7195 | $0.4064 | $3.9157 | -82.60% |
| December, 2027 | $6.2933 | $2.1355 | $7.2533 | -36.33% |
Core Laboratories Inc Stock (CLB) Price Forecast for 2028
In 2028, Core Laboratories Inc (CLB) is projected to reach an average price of $9.3577, with a high projection of $15.11 and a low estimate of $3.605. This indicates an -5.33% fall from the last price of $9.885.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $7.7331 | $5.5212 | $9.2453 | -21.77% |
| February, 2028 | $6.177 | $3.605 | $8.1691 | -37.51% |
| March, 2028 | $11.12 | $4.6729 | $11.40 | +12.50% |
| April, 2028 | $10.02 | $9.3096 | $12.96 | +1.41% |
| May, 2028 | $6.4544 | $5.7144 | $12.94 | -34.71% |
| June, 2028 | $9.0782 | $6.1203 | $10.44 | -8.16% |
| July, 2028 | $8.488 | $6.7901 | $9.5901 | -14.13% |
| August, 2028 | $11.74 | $8.3999 | $13.28 | +18.78% |
| September, 2028 | $11.23 | $8.1856 | $11.64 | +13.56% |
| October, 2028 | $12.42 | $9.7576 | $15.11 | +25.60% |
| November, 2028 | $11.35 | $10.42 | $13.56 | +14.81% |
| December, 2028 | $11.57 | $10.85 | $13.89 | +17.08% |
Core Laboratories Inc Stock (CLB) Price Forecast for 2029
The 2029 price forecast for Core Laboratories Inc Stock (CLB) is $8.2764 on average, with a high prediction of $14.38 and a low estimate of $2.172. This represents an -16.27% decrease from the previous price of $9.885.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $9.5129 | $9.365 | $12.69 | -3.76% |
| February, 2029 | $6.0567 | $6.0167 | $10.20 | -38.73% |
| March, 2029 | $5.8005 | $5.1705 | $6.6286 | -41.32% |
| April, 2029 | $3.8703 | $3.3503 | $6.9524 | -60.85% |
| May, 2029 | $3.0741 | $2.5141 | $5.2141 | -68.90% |
| June, 2029 | $3.3579 | $2.172 | $3.6578 | -66.03% |
| July, 2029 | $5.6477 | $3.6039 | $5.9077 | -42.87% |
| August, 2029 | $5.6516 | $5.1816 | $6.8596 | -42.83% |
| September, 2029 | $6.8954 | $4.4035 | $7.1454 | -30.24% |
| October, 2029 | $7.5952 | $6.4433 | $7.8973 | -23.16% |
| November, 2029 | $12.08 | $7.6911 | $13.53 | +22.20% |
| December, 2029 | $8.8488 | $8.3688 | $14.38 | -10.48% |
Core Laboratories Inc Stock (CLB) Price Forecast for 2030
Core Laboratories Inc Stock (CLB) is expected to reach an average price of $6.2845 in 2030, with a high forecast of $11.70 and a low forecast of $0.87. This signifies an -36.42% decrease from the last price of $9.885.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $6.5026 | $5.8926 | $9.3407 | -34.22% |
| February, 2030 | $9.4664 | $6.4286 | $9.5723 | -4.23% |
| March, 2030 | $8.6902 | $6.7143 | $10.16 | -12.09% |
| April, 2030 | $10.32 | $8.5762 | $11.70 | +4.40% |
| May, 2030 | $6.8539 | $6.6439 | $11.21 | -30.66% |
| June, 2030 | $9.9477 | $6.7601 | $10.07 | +0.63% |
| July, 2030 | $6.5775 | $6.4375 | $11.11 | -33.46% |
| August, 2030 | $5.9113 | $3.4594 | $6.6534 | -40.20% |
| September, 2030 | $3.3811 | $0.87 | $6.5372 | -65.80% |
| October, 2030 | $2.5149 | $1.873 | $3.997 | -74.56% |
| November, 2030 | $2.2287 | $1.5537 | $3.5209 | -77.45% |
| December, 2030 | $4.0185 | $2.3147 | $4.2085 | -59.35% |
3.63%
2.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):